Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.
Cysteine proteinases of Fasciola hepatica are important candidates for vaccine antigens because of their role in fluke biology and host-parasite relationships. In our previous experiments, we found that a recombinant cysteine proteinase cloned from adult F. hepatica (CPFhW) can protect rats against liver fluke infections when it is administered intramuscularly or intranasally in the form of cDNA. We also observed considerable protection upon challenge following mucosal vaccination with inclusion bodies containing recombinant CPFhW produced in Escherichia coli. In this study, we explore oral vaccination, which may be the desired method of delivery and is potentially capable of preventing infections at the site of helminth entry. To provide antigen encapsulation and to protect the vaccine antigen from degradation in the intestinal tract, transgenic plant-based systems are used.



In the present study, we aimed to evaluate the protective ability of mucosal vaccinations of 12-week-old rats with CPFhW produced in a transgenic-plant-based system. To avoid inducing tolerance and to maximise the immune response induced by oral immunisation, we used the hepatitis B virus (HBV) core protein (HBcAg) as a carrier. Animals were immunised with two doses of the antigen and challenged with 25 or 30 metacercariae of F. hepatica.



We obtained substantial protection after oral administration of the plant-produced hybrids of CPFhW and HBcAg. The highest level of protection (65.4%) was observed in animals immunised with transgenic plants expressing the mature CPFhW enzyme flanked by Gly-rich linkers and inserted into c/e1 epitope of truncated HBcAg. The immunised rats showed clear IgG1 and IgM responses to CPFhW for 4 consecutive weeks after the challenge.
Department of Bioengineering, Institute of Biotechnology and Antibiotics, Warsaw, Poland.
Malgorzata
0000-0003-1363-7986
M
Kesik-Brodacka
Division of Parasitology, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Agnieszka
A
Lipiec
Witold Stefański Institute of Parasitology, Polish Academy of Sciences, Warsaw, Poland.
Monika
M
Kozak Ljunggren
Witold Stefański Institute of Parasitology, Polish Academy of Sciences, Warsaw, Poland.
Luiza
L
Jedlina
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Katarzyna
K
Miedzinska
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Magdalena
M
Mikolajczak
Department of Bioengineering, Institute of Biotechnology and Antibiotics, Warsaw, Poland.
Andrzej
A
Plucienniczak
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Andrzej B
AB
Legocki
Witold Stefański Institute of Parasitology, Polish Academy of Sciences, Warsaw, Poland.
Halina
H
Wedrychowicz
D000284:Administration, Oral; D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood*; D000947:Antigens, Helminth / Q000008:administration & dosage / Q000276:immunology*; D057056:Cysteine Proteases / Q000008:administration & dosage / Q000276:immunology*; D018076:DNA, Complementary / Q000008:administration & dosage; D005210:Fasciola hepatica; D005211:Fascioliasis / Q000517:prevention & control*; D006790:Host-Parasite Interactions; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D058488:Metacercariae / Q000472:pathogenicity; D030821:Plants, Genetically Modified; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology; D014611:Vaccination / Q000379:methods; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000627:therapeutic use*
D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D018076:DNA, Complementary; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011994:Recombinant Proteins; D019444:Vaccines, DNA; D057056:Cysteine Proteases